CSat Investment Advisory’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-529
Closed -$27K 650
2020
Q3
$27K Buy
529
+69
+15% +$3.54K ﹤0.01% 785
2020
Q2
$23K Buy
460
+116
+34% +$6.26K ﹤0.01% 796
2020
Q1
$18K Buy
344
+62
+22% +$3.58K ﹤0.01% 745
2019
Q4
$16K Buy
282
+36
+15% +$1.95K ﹤0.01% 846
2019
Q3
$12K Buy
246
+35
+17% +$1.76K ﹤0.01% 853
2019
Q2
$11K Buy
+211
New +$10.2K ﹤0.01% 837

Other funds holding EHC

CSat Investment Advisory's EHC Position: Q4 2020 in Review

CSat Investment Advisory sold out of Encompass Health (EHC) in Q4 2020, closing a stake of 529 shares — an estimated $27K sold.

CSat Investment Advisory first reported a position in EHC in Q2 2019 and held it in 6 quarters. The position peaked at $27K in Q3 2020. 404 funds tracked by Wall St. Rank hold EHC as of Q4 2020.

  • CSat Investment Advisory reported no remaining Encompass Health position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 529 Encompass Health shares in Q4 2020, an estimated $27K.
  • CSat Investment Advisory first reported a position in Encompass Health in Q2 2019 and held it in 6 quarters.
  • CSat Investment Advisory's Encompass Health position peaked at $27K in Q3 2020.
  • 404 funds tracked by Wall St. Rank held Encompass Health as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.